Biomarkers of cyclin-dependent kinase modulation

Details for Australian Patent Application No. 2004262369 (hide)

Owner Bristol-Myers Squibb Company

Inventors Wong, Tai W.; Webster, Kevin R.; Li, Martha; Jackson, Donald G.; Rupnow, Brent A.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2004262369

PCT Pub. Number WO2005/012875

Priority 60/490,890 29.07.03 US

Filing date 29 July 2004

Wipo publication date 10 February 2005

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

16 February 2006 PCT application entered the National Phase

  PCT publication WO2005/012875 Priority application(s): WO2005/012875

25 February 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004262370-Parallel recovery by non-failed nodes

2004262368-Wireless activation system and method